BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 31801631)

  • 21. Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.
    Kouam MK; Tchatchueng-Mbougua JB; Demanou M; Boussinesq M; Pion SD; Kamgno J
    Parasit Vectors; 2013 Sep; 6(1):283. PubMed ID: 24289520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.
    Wanji S; Tendongfor N; Esum M; Yundze SS; Taylor MJ; Enyong P
    Filaria J; 2005 Apr; 4(1):2. PubMed ID: 15817124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
    Esum M; Wanji S; Tendongfor N; Enyong P
    Trans R Soc Trop Med Hyg; 2001; 95(6):673-6. PubMed ID: 11816443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability of test and treat with doxycycline against Onchocerciasis in an area of persistent transmission in Massangam Health District, Cameroon.
    Nditanchou R; Dixon R; Atekem K; Akongo S; Biholong B; Ayisi F; Nwane P; Wilhelm A; Basnet S; Selby R; Wanji S; Bakajika D; Oye J; Kamgno J; Boakye D; Schmidt E; Senyonjo L
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011185. PubMed ID: 37018235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful control of onchocerciasis vectors in San Vicente Pacaya, Guatemala, 1984-1989.
    Ochoa JO; Castro JC; Barrios VM; Juarez EL; Tada I
    Ann Trop Med Parasitol; 1997 Jul; 91(5):471-9. PubMed ID: 9329983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Onchocerciasis in the Amazonian focus of southern Venezuela: altitude and blackfly species composition as predictors of endemicity to select communities for ivermectin control programmes.
    Vivas-Martinez S; Basáñez MG; Grillet ME; Weiss H; Botto C; García M; Villamizar NJ; Chavasse DC
    Trans R Soc Trop Med Hyg; 1998; 92(6):613-20. PubMed ID: 10326102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost of implementing a doxycycline test-and-treat strategy for onchocerciasis elimination among settled and semi-nomadic groups in Cameroon.
    Trotignon G; Dixon R; Atekem K; Senyonjo L; Kamgno J; Biholong D; Jones I; Nditanchou R
    PLoS Negl Trop Dis; 2023 Oct; 17(10):e0011670. PubMed ID: 37851655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loiasis is endemic in the Ndikinimeki Health District (Centre Region, Cameroon) but does not represent a hindrance to onchocerciasis elimination.
    Sumo L; Ntonifor NH; Afor AR; Bopda J; Bamou Heumou R; Ondoua Nganjou GS; Nana Djeunga HC
    Acta Trop; 2022 Jan; 225():106218. PubMed ID: 34755644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of repeated mass ivermectin administration using a community directed approach on
    Amambo GN; Fombad FF; Chounna Ndongmo PW; Abong RA; Njouendou AJ; Beng AA; Nji TM; Esum ME; Fru-Cho J; Manuel R; Kebede D; Enyong PI; Hoerauf A; Koudou B; Bockarie M; Wanji S
    Parasite Epidemiol Control; 2024 May; 25():e00343. PubMed ID: 38405181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eliminating onchocerciasis within the Meme River Basin of Cameroon: A social-ecological approach to understanding everyday realities and health systems.
    Nji TM; Piotrowski H; Dum-Buo N; Fung EG; Dean L; Theobald S; Thomson R; Wanji S; Ozano K
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009433. PubMed ID: 34077416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon.
    Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Abong RA; Enyong P; Taylor DW
    Parasit Vectors; 2015 Dec; 8():667. PubMed ID: 26715524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon.
    Lenk EJ; Moungui HC; Boussinesq M; Kamgno J; Nana-Djeunga HC; Fitzpatrick C; Peultier AMM; Klion AD; Fletcher DA; Nutman TB; Pion SD; Niamsi-Emalio Y; Redekop WK; Severens JL; Stolk WA
    Clin Infect Dis; 2020 Apr; 70(8):1628-1635. PubMed ID: 31165855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.
    Kamgno J; Nana-Djeunga HC; Pion SD; Chesnais CB; Klion AD; Mackenzie CD; Nutman TB; Boussinesq M
    Int Health; 2018 Mar; 10(suppl_1):i49-i53. PubMed ID: 29471340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward.
    Ndyomugyenyi R; Lakwo T; Habomugisha P; Male B
    Ann Trop Med Parasitol; 2007 Jun; 101(4):323-33. PubMed ID: 17524247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community-directed vector control to supplement mass drug distribution for onchocerciasis elimination in the Madi mid-North focus of Northern Uganda.
    Jacob BG; Loum D; Lakwo TL; Katholi CR; Habomugisha P; Byamukama E; Tukahebwa E; Cupp EW; Unnasch TR
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006702. PubMed ID: 30148838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
    Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
    N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea.
    Guillet P; Sékétéli A; Alley ES; Agoua H; Boatin BA; Bissan Y; Akpoboua LK; Quillévéré D; Samba EM
    Bull World Health Organ; 1995; 73(2):199-205. PubMed ID: 7743591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.
    Verver S; Walker M; Kim YE; Fobi G; Tekle AH; Zouré HGM; Wanji S; Boakye DA; Kuesel AC; de Vlas SJ; Boussinesq M; Basáñez MG; Stolk WA
    Clin Infect Dis; 2018 Jun; 66(suppl_4):S267-S274. PubMed ID: 29860291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.